Study #2021-0618
Phase I trial evaluating the safety and tolerability of chemoradiation followed by chemotherapy + dostarlimab for stage IIIC, node positive, endometrial cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Paclitaxel, Carboplatin, Dostarlimab, Cisplatin
Description
To learn if chemotherapy given in combination with radiation therapy, followed by maintenance therapy, can help to control endometrial cancer. The safety and effects of this study treatment will also be studied
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Endometrial Cancer
Study phase:
Phase I
Physician name:
Pamela Soliman
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.